<?xml version="1.0" encoding="UTF-8"?>
<p>The overall incidence of chronic GvHD in our study was lower in the UCB and Haplo/PTCY HCT cohorts than in the 1-mMUD HCT cohort, similar to results of previous studies.
 <sup>
  <xref rid="b9-1040835" ref-type="bibr">9</xref>–
  <xref rid="b17-1040835" ref-type="bibr">17</xref>
 </sup> The overall incidence of chronic GvHD after 1-mMUD HCT was higher in our study than in previous reports.
 <sup>
  <xref rid="b9-1040835" ref-type="bibr">9</xref>,
  <xref rid="b11-1040835" ref-type="bibr">11</xref>,
  <xref rid="b13-1040835" ref-type="bibr">13</xref>,
  <xref rid="b17-1040835" ref-type="bibr">17</xref>–
  <xref rid="b21-1040835" ref-type="bibr">21</xref>
 </sup> This difference may be explained by the higher proportion of bone marrow grafts and more frequent use of T-cell depletion in the previous studies.
 <sup>
  <xref rid="b9-1040835" ref-type="bibr">9</xref>,
  <xref rid="b11-1040835" ref-type="bibr">11</xref>,
  <xref rid="b13-1040835" ref-type="bibr">13</xref>,
  <xref rid="b17-1040835" ref-type="bibr">17</xref>,
  <xref rid="b18-1040835" ref-type="bibr">18</xref>,
  <xref rid="b22-1040835" ref-type="bibr">22</xref>
 </sup> Older age could also be a contributor to the higher rates of chronic GvHD in the 1-mMUD group compared to the UCB and Haplo/PTCY groups.
</p>
